T. Rowe Price Associates’s Zepp Health ZEPP Stock Holding History

T. Rowe Price Associates’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Sell	311,854 -59	-0%	-$618	﹤0.01%	2113
2026 Q1	$3.73M	Buy	311,913 +15,946	+5%	+$326K	﹤0.01%	1548
2025 Q4	$7.97M	Buy	295,967 +44,619	+18%	+$1.59M	﹤0.01%	1276
2025 Q3	$11.5M	Buy	+251,348	New	+$7.61M	﹤0.01%	1192
2019 Q4	–	Sell	-23,417	Closed	-$937K	–	2555
2019 Q3	$937K	Sell	23,417 -5,534	-19%	-$232K	﹤0.01%	1850
2019 Q2	$1.16M	Sell	28,951 -14,092	-33%	-$588K	﹤0.01%	1788
2019 Q1	$2.25M	Buy	+43,043	New	+$2.32M	﹤0.01%	1557

Other funds holding ZEPP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates's ZEPP Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Zepp Health (ZEPP) stake by 0.02% in Q2 2026, selling an estimated $618 and leaving 311,854 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

T. Rowe Price Associates first reported a position in ZEPP in Q1 2019 and has held it in 7 quarters since. The position peaked at $11.5M in Q3 2025. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

T. Rowe Price Associates held 311,854 shares of Zepp Health worth $1.63M as of Q2 2026.
T. Rowe Price Associates sold 59 Zepp Health shares in Q2 2026, an estimated $618.
Zepp Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2113 holding.
T. Rowe Price Associates first reported a position in Zepp Health in Q1 2019 and has held it in 7 quarters since.
T. Rowe Price Associates's Zepp Health position peaked at $11.5M in Q3 2025.
28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.